儿童急性呼吸窘迫综合征的药物管理

陆国平; 王一雪

doi:10.7499/j.issn.1008-8830.2018.09.001

PDF(944 KB)

HTML

中国当代儿科杂志 ›› 2018, Vol. 20 ›› Issue (9) : 697-700. DOI: 10.7499/j.issn.1008-8830.2018.09.001

ARDS专题

儿童急性呼吸窘迫综合征的药物管理

陆国平, 王一雪

作者信息 +

Drug management of pediatric acute respiratory distress syndrome

LU Guo-Ping, WANG Yi-Xue

Author information +

文章历史 +

摘要

该文回顾了2015版儿童急性肺损伤共识会议发布的儿童急性呼吸窘迫综合征（ARDS）新共识和近年来发表的ARDS药物治疗的相关文献，总结了儿童ARDS的药物管理要点，为儿童ARDS的治疗提供依据。

Abstract

This article reviewed the Consensus Recommendations on Pediatric Acute Respiratory Distress Syndrome (ARDS) from the Pediatric Acute Lung Injury Consensus Conference in 2015 and the literature related to drug management of ARDS. The main points of drug management of pediatric ARDS were summarized.

导出引用

陆国平, 王一雪. 儿童急性呼吸窘迫综合征的药物管理[J]. 中国当代儿科杂志. 2018, 20(9): 697-700 https://doi.org/10.7499/j.issn.1008-8830.2018.09.001

LU Guo-Ping, WANG Yi-Xue. Drug management of pediatric acute respiratory distress syndrome[J]. Chinese Journal of Contemporary Pediatrics. 2018, 20(9): 697-700 https://doi.org/10.7499/j.issn.1008-8830.2018.09.001

参考文献

[1] Day RW, Allen EM, Witte MK. A randomized, controlled study of the 1-hour and 24-hour effects of inhaled nitric oxide therapy in children with acute hypoxemic respiratory failure[J]. Chest, 1997, 112(5):1324-1331.
[2] Dobyns EL, Anas NG, Fortenberry JD, et al. Interactive effects of high-frequency oscillatory ventilation and inhaled nitric oxide in acute hypoxemic respiratory failure in pediatrics[J]. Crit Care Med, 2002, 30(11):2425-2429.
[3] Afshari A, Brok J, Møller AM, et al. Inhaled nitric oxide for acute respiratory distress syndrome and acute lung injury in adults and children:a systematic review with meta-analysis and trial sequential analysis[J]. Anesth Analg, 2011, 112(6):1411-1421.
[4] Pediatric Acute Lung Injury Consensus Conference Group. Pediatric acute respiratory distress syndrome:consensus recommendations from the Pediatric Acute Lung Injury Consensus Conference[J]. Pediatr Crit Care Med, 2015, 16(5):428-439.
[5] Willson DF, Thomas NJ, Tamburro R, et al. Pediatric calfactant in acute respiratory distress syndrome trial[J]. Pediatr Crit Care Med, 2013, 14(7):657-665.
[6] Valentine SL, Nadkarni VM, Curley MAQ; Pediatric Acute LungInjury Consensus Conference Group. Non-pulmonary treatments for pediatric acute respiratory distress syndrome:proceedings from the Pediatric Acute Lung Injury Consensus Conference[J]. Pediatr Crit Care Med, 2015, 16(5 Suppl 1):S73-S85.
[7] Guglani L, Jain S, Lodha R. Methylprednisolone therapy in a child with unresolving ARDS[J]. Indian Pediatr, 2006, 43(7):639-642.
[8] Willson DF, Thomas NJ, Tamburro R, et al. Pediatric calfactant in acute respiratory distress syndrome trial[J]. Pediatr Crit Care Med, 2013, 14(7):657-665.
[9] Tamburro RF, Kneyber MCJ; Pediatric Acute Lung Injury Consensus Conference Group. Pulmonary specific ancillary treatment for pediatric acute respiratory distress syndrome:proceedings from the Pediatric Acute Lung Injury Consensus Conference[J]. Pediatr Crit Care Med, 2015, 16(5 Suppl 1):S61-S72.
[10] Papazian L, Forel JM, Gacouin A, et al. Neuromuscular blockers in early acute respiratory distress syndrome[J]. N Engl J Med, 2010, 363(12):1107-1116.
[11] Wilsterman MEF, de Jager P, Blokpoel R, et al. Short-term effects of neuromuscular blockade on global and regional lung mechanics, oxygenation and ventilation in pediatric acute hypoxemic respiratory failure[J]. Ann Intensive Care, 2016, 6(1):103.
[12] Pediatric Acute Lung Injury Consensus Conference Group. Pediatric acute respiratory distress syndrome:consensus recommendations from the Pediatric Acute Lung Injury Consensus Conference[J]. Pediatr Crit Care Med, 2015, 16(5):428-439.
[13] Abdelsalam M, Cheifetz IM. Goal-directed therapy for severely hypoxic patients with acute respiratory distress syndrome:permissive hypoxemia[J]. Respir Care, 2010, 55(11):1483-1490.
[14] Randolph AG. Management of acute lung injury and acute respiratory distress syndrome in children[J]. Crit Care Med, 2009, 37(8):2448-2454.